Multitasking Plasmonic Nanobubbles Kill Diseased Cells, Modify Others
http://www.sciencedaily.com/releases/2012/12/...145950.htm
ScienceDaily (Dec. 3, 2012) — Researchers at Rice University have found a way to kill some diseased cells and treat others in the same sample at the same time. The process activated by a pulse of laser light leaves neighboring healthy cells untouched.
The unique use for tunable plasmonic nanobubbles developed in the Rice lab of Dmitri Lapotko shows promise to replace several difficult processes now used to treat cancer patients, among others, with a fast, simple, multifunctional procedure.
The research is the focus of a paper published online this week by the American Chemical Society journal ACS Nano and was carried out at Rice by biochemist Lapotko, research scientist and lead author Ekaterina Lukianova-Hleb and undergraduate student Martin Mutonga, with assistance from the Center for Cell and Gene Therapy at Baylor College of Medicine (BCM), Texas Children's Hospital and the University of Texas MD Anderson Cancer Center.
Plasmonic nanobubbles that are 10,000 times smaller than a human hair cause tiny explosions. The bubbles form around plasmonic gold nanoparticles that heat up when excited by an outside energy source -- in this case, a short laser pulse -- and vaporize a thin layer of liquid near the particle's surface. The vapor bubble quickly expands and collapses. Lapotko and his colleagues had already found that plasmonic nanobubbles kill cancer cells by literally exploding them without damage to healthy neighbors, a process that showed much higher precision and selectivity compared with those mediated by gold nanoparticles alone, he said.
The new project takes that remarkable ability a few steps further. A series of experiments proved a single laser pulse creates large plasmonic nanobubbles around hollow gold nanoshells, and these large nanobubbles selectively destroy unwanted cells. The same laser pulse creates smaller nanobubbles around solid gold nanospheres that punch a tiny, temporary pore in the wall of a cell and create an inbound nanojet that rapidly "injects" drugs or genes into the other cells.
In their experiments, Lapotko and his team placed 60-nanometer-wide hollow nanoshells in model cancer cells and stained them red. In a separate batch, they put 60-nanometer-wide nanospheres into the same type of cells and stained them blue.
After suspending the cells together in a green fluorescent dye, they fired a single wide laser pulse at the combined sample, washed the green stain out and checked the cells under a microscope. The red cells with the hollow shells were blasted apart by large plasmonic nanobubbles. The blue cells were intact, but green-stained liquid from outside had been pulled into the cells where smaller plasmonic nanobubbles around the solid spheres temporarily pried open the walls.
Because all of this happens in a fraction of a second, as many as 10 billion cells per minute could be selectively processed in a flow-through system like that under development at Rice, said Lapotko, a faculty fellow in biochemistry and cell biology and in physics and astronomy. That has potential to advance cell and gene therapy and bone marrow transplantation, he said.
Most disease-fightingand gene therapies require "ex vivo" -- outside the body -- processing of human cell grafts to eliminate unwanted (like cancerous) cells and to genetically modify other cells to increase their therapeutic efficiency, Lapotko said. "Current cell processing is often slow, expensive and labor intensive and suffers from high cell losses and poor selectivity. Ideally both elimination and transfection (the introduction of materials into cells) should be highly efficient, selective, fast and safe."
Plasmonic nanobubble technology promises "a method of doing multiple things to a cell population at the same time," said Malcolm Brenner, a professor of medicine and of pediatrics at BCM and director of BCM's Center for Cell and Gene Therapy, who collaborates with the Rice team. "For example, if I want to put something into a stem cell to make it turn into another type of cell, and at the same time kill surrounding cells that have the potential to do harm when they go back into a patient -- or into another patient -- these very tunable plasmonic nanobubbles have the potential to do that."
The long-term objective of a collaborative effort among Rice, BCM, Texas Children's Hospital and MD Anderson is to improve the outcome for patients with diseases whose treatment requires ex vivo cell processing, Lapotko said.
Lapotko plans to build a prototype of the technology with an eye toward testing with human cells in the near future. "We'd like for this to be a universal platform for cell and gene therapy and for stem cell transplantation," he said.
The work was supported by the National Institutes of Health
Multitasking Plasmonic Nanobubbles Kill Diseased Cells,
Top 10 Most Recent News Articles
Insider Risk Makes Human Judgment a Security Priority
A badge, a password, and a locked gate can all look reassuring right up until the person holding them starts to crack. Signpost Six's new report, The Psychology of Insider Risk, lands on an uncomfortable truth: the most consequential security weakness may not be a system at all. It may be an employee under strain, in conflict, in debt, making a mistake, or being quietly...
Continue Reading
U.S. Patriot's Veteran Hiring Earns a Real National Nod
A workforce award can be cheap wallpaper, but this one has some heft. U.S. Patriot, the veteran-founded and veteran-led military goods retailer owned by GALLS, landed on Military Times’ 2026 Best for Vets: Employers list, placing third in retail and first in Kentucky. The recognition covers 250 organizations, and this is U.S. Patriot’s fourth consecutive appearance....
Continue ReadingVeriSilicon's New AI/AR Glasses Tech: Game-Changer?
VeriSilicon Unveils Next-Generation Subsystem There's some sizzle in the air with VeriSilicon's latest move in the wearable tech arena. They’ve launched a low-power, high-performance subsystem aimed squarely at AI and augmented reality glasses. Now, these gizmos aren't just the stuff of science fiction. Thanks to their Nano-XR series, reality might just get a splash...
Continue Reading
Ambition Links Call Scoring to the Coaching Room Faster
A sales call dies twice when nobody turns the recording into practice. First it ends with the prospect, then it vanishes into a pile of transcripts, dashboards, and manager good intentions. Ambition’s new Call Intelligence feature is aimed squarely at that second failure. It brings Gong calls, transcripts, scorecards, and trackers into Ambition’s coaching workflow,...
Continue Reading
Trilith Holiday Tour Blends Film Access and Giving
Snow machines, trolley rides, and a mental-health subsidy are sharing the same stage in Fayetteville this holiday season. That is an unusual mix, but it fits Trilith Foundation’s stated mission better than another generic lights-and-cocoa event ever could. From Nov. 21 through Dec. 31, the Foundation is turning its guided Trilith Studios tour into a seasonal experience...
Continue Reading
illumine Targets Childcare Chain Control and Risk Gaps
Expansion Gets Messy Before It Gets Impressive Childcare operators do not usually stumble because they forgot how to care for children; they stumble because the back office fractures as the network grows. One center handles fees one way, another lets enrollment leads work a different funnel, and headquarters discovers too late that its reports are arguing with each other....
Continue Reading
Scribd’s First Safety Report Shows Enforcement at Scale
Forty-seven million enforcement actions is not a decorative statistic Scribd finally put some hard numbers on a problem most document platforms prefer to discuss in foggy corporate language. Its first transparency report, covering January through June 2026, says the company took more than 47 million moderation actions across Scribd and Slideshare. That is a hulking...
Continue Reading
Skanska Adds $80M U.S. Tech Facility Contract to Orders
An $80 million add-on is the sort of construction news that looks modest until you remember what it says about the customer relationship. Skanska has won an additional contract from an existing client for a U.S. tech facility, worth roughly SEK 760 million, and it will enter U.S. order bookings in the fourth quarter of 2026. No fireworks, no grand strategic...
Continue Reading
Inhibrx Ewing Data Gives Ozekibart a Real Clinical Signal
Numbers this lopsided in relapsed Ewing sarcoma make me sit up straight, even after years of watching oncology releases try to turn every blip into a brass band. Inhibrx has reported updated Phase 1/2 data for ozekibart, paired with irinotecan and temozolomide, that look genuinely notable in a disease where patients have very few good cards left to play. That matters...
Continue Reading
Vuzix Bets on Lightweight Color Glasses for OEM Partners
Forty grams is where this story gets interesting, because faces are ruthless product testers. People will tolerate plenty of clever technology right up until it pinches, looks goofy, leaks light, or makes them feel like they are wearing a science project. Vuzix is trying to clear that hurdle with Ultralite Color, a full-color AI eyewear reference platform built for OEM...
Continue ReadingTop 5 Most Recently Viewed Articles
Prinses Máxima Center Enhances Genomics with Callisto™ Innovation
Prinses Máxima Center's Partnership with Volta Labs The Prinses Máxima Center for Pediatric Oncology is making headlines with its recent acquisition of the Callisto™ platform from Volta Labs. This major step forward aims to enhance efficiency in sample preparation across a variety of genomics workflows, specifically designed for both Illumina and Oxford Nanopore...
Continue Reading
Keros Therapeutics to Showcase Innovations at Key Conferences
Exciting Participation of Keros Therapeutics in Major Conferences Keros Therapeutics, Inc. is making significant strides in the biopharmaceutical landscape by focusing on innovative therapies targeting disorders associated with the TGF-ß family of proteins. Recently, the company announced that its Chair and Chief Executive Officer, Jasbir S. Seehra, Ph.D., will represent...
Continue Reading
KULR Technology Unveils Major Licensing Breakthrough with Japan
KULR Technology Group, Inc. (NYSE American: KULR) unveiled a major licensing agreement back in 2024 that had traders buzzing. This $2.35 million deal centered around their vibration reduction technology, known as KULR Xero Vibe (KXV). At first glance, it seemed like a solid step for the company into new markets, but let’s peel back the layers and see what's really...
Continue Reading
Mainz Biomed Achieves Significant Milestones and Results
Mainz Biomed Reports Financial Results and Strategic Progress Lab network revenue up by 33% year-over-year. Operating loss down by 30% and net loss by 18%. Partnerships driving innovation and growth forward. Highlighting 2025 accomplishments and future goals. Mainz Biomed N.V. (NASDAQ: MYNZ), a pioneering molecular genetics diagnostic firm, has reported its financial...
Continue Reading
PioCreat Launches Innovative Mini Dental 3D Printer During Expo
PioCreat Launches Innovative Mini Dental 3D Printer at Moscow Event PioCreat, a well-respected name in the 3D printing sector, made a significant impression at the dental industry's notable event, the 2025 Moscow Dental Expo. This gathering, renowned for showcasing advancements in digital dentistry, took place at Crocus-Expo IEC, attracting a wide array of international...
Continue Reading